Antigua and Barbuda vs Tonga: Immunization, Hib3
Antigua and Barbuda
99.0%
in 2024
Tonga
99.0%
in 2024
Antigua and Barbuda rank
1st
Tonga rank
1st
Immunization, Hib3 over time
- Antigua and Barbuda
- Tonga
How they compare
Antigua and Barbuda currently reports 99.0% against 99.0% in Tonga, a difference of 0.0%.
The two have swapped places 4 times across 20 shared years of data; in 2005 it was Tonga ahead.
Antigua and Barbuda ranks 1st and Tonga ranks 1st of 191 countries.
Tonga has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Antigua and Barbuda | Tonga | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 97.6% | 99.0% | 1.4% | Tonga |
| 2010s | 97.3% | 97.9% | 0.6% | Tonga |
| 2020s | 97.4% | 99.0% | 1.6% | Tonga |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hib3, Antigua and Barbuda or Tonga?
- Antigua and Barbuda, at 99.0% against 99.0% in Tonga as of 2024.
- What is the difference in immunization, hib3 between Antigua and Barbuda and Tonga?
- 0.0%, with Antigua and Barbuda ahead.
- How many years of comparable data are there for Antigua and Barbuda and Tonga?
- 20 years are reported by both, from 2005 to 2024.
- How do Antigua and Barbuda and Tonga rank globally for immunization, hib3?
- Antigua and Barbuda ranks 1st and Tonga ranks 1st of 191 countries.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, Hib3 (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.